How to Validate a New FBS Lot: A Step-by-Step Protocol for Cell Culture Labs
Switching to a new FBS lot — whether from a new origin, a new supplier, or simply the next production batch — carries real risk if done without a structured validation. This protocol walks you through every step: what to test, which controls to run, and how to document your results.
Why FBS Lot Validation Matters More Than Ever
FBS is not a chemically defined reagent. Every lot is a biological material with inherent variability — in protein composition, growth factor concentration, endotoxin levels, haemoglobin content, and undefined bioactive factors. Two lots from the same supplier and the same origin can perform very differently in sensitive applications. In a shortage environment, where labs are under pressure to accept whatever lot is available, validating before committing to a large order is not optional — it is the most important supply chain step you can take.
What to Validate: Quick Application Guide
| Application | Critical Parameters | Validation Assays |
|---|---|---|
| General mammalian cell culture (CHO, HEK293, Vero) | Growth support, viability | Proliferation assay, trypan blue viability |
| Primary human cells (PBMCs, fibroblasts, endothelial) | Growth support, cytokine background, immunoglobulin interference | Proliferation + functional assay (e.g. cytokine release) |
| Hybridoma / mAb production | IgG contamination (ultra-low IgG grade required), cloning efficiency | Cloning efficiency assay, Protein A binding check |
| ES / iPSC culture | Differentiation potential, pluripotency markers | Colony morphology, Oct4/Sox2 expression, EB formation |
| Viral vector production (AAV, lentivirus) | Transduction efficiency, serum endotoxin | Titration assay, LAL endotoxin test |
| GMP / regulated manufacturing | All of the above + full CoA review, origin certificate, TSE/BSE statement | Full QC panel including mycoplasma, sterility |
The Validation Protocol — Step by Step
Request test volume and review the Certificate of Analysis
Before running any cell-based assays, review the CoA from your supplier. Key parameters to check: total protein (typically 35–45 mg/mL for standard FBS), haemoglobin (<25 mg/dL for low-haemoglobin grade), endotoxin (<10 EU/mL standard; <5 EU/mL low endotoxin; <1 EU/mL ultra-low), pH (6.8–7.6), osmolality (260–340 mOsm/kg), mycoplasma negative, sterility pass.
Request a test volume of 100–500 mL — sufficient to run at least 3 independent validation experiments in parallel with your current reference lot.
Prepare both lots identically for testing
Thaw the test lot and your current reference lot under identical conditions (37 °C water bath, <30 min). Heat-inactivate both if your protocol requires it (56 °C, 30 min). Aliquot and store identically. Do not introduce any variable between the two lots other than the lot identity itself.
Run a proliferation / growth assay with your most sensitive cell line
Seed your most serum-sensitive cell line at a defined density in triplicate wells using both the reference lot and the test lot at your standard working concentration (typically 5–10%). Count cells (or measure absorbance via MTT/MTS) at 48 h and 96 h. Calculate growth rate and doubling time. Acceptance criterion: test lot growth rate within ±15–20% of the reference lot, or as defined by your internal specification.
Run your application-specific functional assay
Growth support alone is not sufficient — validate the lot in the assay context it will actually be used in. For mAb producers: measure antibody titre or cloning efficiency. For diagnostics development: run your target immunoassay and compare signal-to-noise with both lots. For viral vector work: compare transduction efficiency or titration results. This is the most critical step and the one most labs skip when under time pressure.
Run a sterility and mycoplasma check on the test volume
Even if the supplier provides a CoA with mycoplasma negative status, running a rapid PCR-based mycoplasma test on your received material adds an additional layer of assurance and creates a documented in-house record. For regulated manufacturing environments, this is a GMP requirement. For research labs, it is best practice that catches rare shipping or handling contamination events.
Document and make the lot acceptance decision
Record all results in a lot validation report: lot number, origin, supplier, receipt date, test volume, cell line used, assay methods, results vs. acceptance criteria, and final accept/reject decision. Archive the CoA, CoO, and any supplier-provided TSE/BSE or viral safety documentation alongside the report. This record is your reference if the lot is challenged in an audit or regulatory submission.
Reserve the bulk lot before ordering
Once the test volume passes your acceptance criteria, contact your supplier to reserve the remaining lot volume. In a shortage market, validated lots sell out quickly. Lot reservation locks in your tested specifications — you order the same lot you validated, not a substitute.
Free Test Volume — Validate Before You Commit
SeamlessBio ships FBS test volumes (South America, Australia, US origin) for validation against your current lot. No pre-payment. Full documentation included: CoA, CoO, endotoxin result, mycoplasma status, TSE/BSE declaration.
Request a Test Volume View FBS Grades